Sep 06, 2023 / 02:15PM GMT
Timothy Ian Daley - Wells Fargo Securities, LLC, Research Division - Associate Analyst
All right. Great. Thank you, everybody, for being here. This is Tim Daley, Life Science Tools, Diagnostics and Pharma Services Analyst here at Wells Fargo. Welcome to the Healthcare Conference 2023 here in Boston. I'm pleased to have Bio-Techne here with us. We've got Jim Hippel, CFO; and David Clair, Investor Relations here with us on the stage. And we have a bunch of questions for them, a lot of hot topics that currently are on top of mind as well as on top of other companies' minds. And I'll probably leave a little bit of time at the end for Q&A. But just to, I guess, kick it off with the hot topic du jour, any update for us on August? How are things trending versus July, month-to-month volatility has been all over the place depending on end market, geographical market, any changes specifically?
James T. Hippel - Bio-Techne Corporation - Executive VP of Finance & CFO
Honestly, really nothing, no changes to report on since kind of the view we shared at our last
Bio-Techne Corp at Wells Fargo Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot